PARD (Poniard Pharmaceuticals) Pretax Margin %: % (As of Sep. 2011)


What is Poniard Pharmaceuticals Pretax Margin %?

Poniard Pharmaceuticals PARD Pretax Margin % is % as of Sep. 2011.

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Poniard Pharmaceuticals's Pre-Tax Income for the three months ended in Sep. 2011 was $0.00 Mil. Poniard Pharmaceuticals's Revenue for the three months ended in Sep. 2011 was $0.00 Mil. Therefore, Poniard Pharmaceuticals's pretax margin for the quarter that ended in Sep. 2011 was %.

The historical rank and industry rank for Poniard Pharmaceuticals's Pretax Margin % or its related term are showing as below:


PARD's Pretax Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -92.22
* Ranked among companies with meaningful Pretax Margin % only.

Poniard Pharmaceuticals  (OTCPK:PARD) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.

Poniard Pharmaceuticals Pretax Margin % Related Terms

Poniard Pharmaceuticals Pretax Margin % Historical Data

* Premium members only.

The historical data trend for Poniard Pharmaceuticals's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Poniard Pharmaceuticals Pretax Margin % Chart

Poniard Pharmaceuticals Annual Data
Trend Dec01 Dec02 Dec03 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10
Pretax Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Poniard Pharmaceuticals Quarterly Data
Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

PARD vs OBMP, NSPX, ATRX: Pretax Margin % Comparison

For the Biotechnology subindustry, Poniard Pharmaceuticals's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Poniard Pharmaceuticals Pretax Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Poniard Pharmaceuticals's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Poniard Pharmaceuticals's Pretax Margin % falls into.


Poniard Pharmaceuticals Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Poniard Pharmaceuticals's Pretax Margin for the fiscal year that ended in Dec. 2010 is calculated as

Pretax Margin=Pre-Tax Income (A: Dec. 2010 )/Revenue (A: Dec. 2010 )
=0/0
= %

Poniard Pharmaceuticals's Pretax Margin for the quarter that ended in Sep. 2011 is calculated as

Pretax Margin=Pre-Tax Income (Q: Sep. 2011 )/Revenue (Q: Sep. 2011 )
=0/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Pretax Margin % →
What does a Pretax Margin % of % mean?
Poniard Pharmaceuticals (PARD) has a Pretax Margin % of % as of Sep. 2011. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Poniard Pharmaceuticals and its competitors.
Is Poniard Pharmaceuticals' Pretax Margin % too high?
Poniard Pharmaceuticals' current Pretax Margin % is %.
How does Poniard Pharmaceuticals' Pretax Margin % compare to OBMP and NSPX?
Poniard Pharmaceuticals' Pretax Margin % of % can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Biotechnology company?
A good Pretax Margin % depends on the Biotechnology industry context. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Poniard Pharmaceuticals and its competitors. Poniard Pharmaceuticals's current Pretax Margin % is %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Poniard Pharmaceuticals stock overvalued right now?
Poniard Pharmaceuticals (PARD) has a current Pretax Margin % of %. The current Pretax Margin % is %. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Poniard Pharmaceuticals (PARD), the current Pretax Margin % is % as of Sep. 2011. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Poniard Pharmaceuticals Business Description

Address 300 Elliott Avenue West, Suite 530, Seattle, CA, USA, 98119
Poniard Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of cancer therapeutics. Its product candidate is picoplatin, a new generation platinum-based cancer therapy.